Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization

Published:2016-01-29 Issue:6 Volume:76 Page:1476-1484
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Boussemart Lise,Girault Isabelle,Malka-Mahieu Hélène,Mateus Christine,Routier Emilie,Rubington Margot,Kamsu-Kom Nyam,Thomas Marina,Tomasic Gorana,Agoussi Sandrine,Breckler Marie,Laporte Mélanie,Lacroix Ludovic,Eggermont Alexander M.,Cavalcanti Andrea,Grange Florent,Adam Julien,Vagner Stéphan,Robert Caroline

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance;Chemical Biology & Drug Design;2024-09

2. Targeting RAF dimers in RAS mutant tumors: From biology to clinic;Acta Pharmaceutica Sinica B;2024-05

3. Targeting CRAF kinase in anti-cancer therapy: progress and opportunities;Molecular Cancer;2023-12-18

4. Pediatric low-grade glioma: State-of-the-art and ongoing challenges;Neuro-Oncology;2023-11-07

5. Complications following novel therapies for non‐small cell lung cancer;Journal of Internal Medicine;2022-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP